ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Pierre Fabre clinical trials

Part of Pierre Fabre Participations. Source

The registry lists 145 studies whose lead sponsor is Pierre Fabre or one of 6 companies grouped under it. 11 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 30, 2026.

Our grouping of 7 registry names, not the registry’s. See them and correct one ↓

Get an email when these change. Save the Pierre Fabre studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

What it is testing

The drugs Pierre Fabre’s studies test, most open studies first — 18 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 8 more

Coming up

6 of Pierre Fabre’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 1N’26
  2. 1D
  3. J’27
  4. F
  5. 1M
  6. A
  7. M
  8. 2J
  9. J
  10. A
  11. S
  12. O
  13. 1N

Add all 6 to your calendar (.ics) → With an account.

All 145 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now118%Recruiting 10 · Not yet recruiting 1
  • Under way, not recruiting64%
  • Completed10673%
  • Stopped early1712%Terminated 11 · Withdrawn 6
  • Status unknown or other53%

Phase

  • Phase 224
  • Phase 122
  • Phase 319
  • Phase 45

Where

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 1721
  16. 22
  17. 23
  18. 24
  19. 25
  20. 126

By the year each study started; 7 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Pierre Fabre.

  • Pierre Fabre Medicament
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    73 studies →
  • Pierre Fabre Dermo Cosmetique
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    59 studies →
  • Pierre Fabre Pharma GmbH
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →
  • Pierre Fabre Dermatology
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • Pierre Fabre Pharma AG
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Pierre Fabre Ltd
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study
  • Pierre Fabre Medical Devices
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Pierre Fabre leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 145. Browse all 145 →